William E. Gillanders
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
Papers in
-
- Breast Cancer Treatment Studies 29
- Immunology 41
- Immunotherapy and Immune Responses 33
- T-cell and B-cell Immunology 4
- Co-authors
- Rebecca Aft (38 shared papers)David J. Cole (29 shared papers)Timothy J. Eberlein (26 shared papers)Mohamed Labib Salem (12 shared papers)Peter S. Goedegebuure (13 shared papers)Julie A. Margenthaler (26 shared papers)Michael Mitas (14 shared papers)Kaidi Mikhitarian (16 shared papers)
- Journals
- Breast Cancer Research and Treatment (12 papers)The American Journal of Surgery (10 papers)The Journal of Immunology (8 papers)Annals of Surgical Oncology (6 papers)Annals of Surgery (6 papers)
- Partner nations
- United StatesSwitzerlandIreland
In The Last Decade
William E. Gillanders
172 papers receiving 11.8k citations
William E. Gillanders's Hit Papers
Peers
Comparison fields: 5 of 105
- Oncology 2.6k
- Cancer Research 1.3k
- Immunology 2.0k
- Molecular Biology 1.1k
- Pathology and Forensic Medicine 298
Countries citing papers authored by William E. Gillanders
This map shows the geographic impact of William E. Gillanders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William E. Gillanders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William E. Gillanders more than expected).
Fields of papers citing papers by William E. Gillanders
This network shows the impact of papers produced by William E. Gillanders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William E. Gillanders. The network helps show where William E. Gillanders may publish in the future.
Co-authors
The 25 scholars most cited alongside William E. Gillanders, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 177 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens Hit paper breakdown → | 2014 | 1710 |
| 2 | Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts Hit paper breakdown → | 2013 | 533 |
| 3 | 2004 | 482 | |
| 4 | cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity Hit paper breakdown → | 2020 | 457 |
| 5 | 2017 | 407 | |
| 6 | The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution Hit paper breakdown → | 2020 | 385 |
| 7 | 2009 | 376 | |
| 8 | NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor–Positive Breast Cancer Hit paper breakdown → | 2017 | 301 |
| 9 | 2018 | 275 | |
| 10 | 2010 | 237 | |
| 11 | 2012 | 234 | |
| 12 | 2020 | 204 | |
| 13 | 2022 | 189 | |
| 14 | 2019 | 174 | |
| 15 | 2001 | 171 | |
| 16 | 2014 | 170 | |
| 17 | 2007 | 163 | |
| 18 | 2014 | 131 | |
| 19 | Epigenetic regulation during cancer transitions across 11 tumour types Hit paper breakdown → | 2023 | 124 |
| 20 | 2004 | 121 |
About William E. Gillanders
William E. Gillanders is a scholar working on Cancer Research, Immunology, Oncology, Pathology and Forensic Medicine and Molecular Biology, having authored 177 papers that have together received 12.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (33 papers), Breast Cancer Treatment Studies (29 papers), Cancer Immunotherapy and Biomarkers (5 papers), Pancreatic and Hepatic Oncology Research (5 papers), Thyroid and Parathyroid Surgery (5 papers), Global Cancer Incidence and Screening (4 papers), Cancer Cells and Metastasis (4 papers) and T-cell and B-cell Immunology (4 papers). The work is most often cited by research in Oncology (2.6k citations), Cancer Research (1.3k citations), Immunology (2.0k citations), Molecular Biology (1.1k citations) and Pathology and Forensic Medicine (298 citations). William E. Gillanders has collaborated with scholars based in United States, Switzerland and Ireland. Frequent co-authors include Rebecca Aft, David J. Cole, Timothy J. Eberlein, Mohamed Labib Salem, Peter S. Goedegebuure, Julie A. Margenthaler, Michael Mitas, Kaidi Mikhitarian, Narendra V. Sankpal and Brian A. Belt. Their work appears in journals such as Breast Cancer Research and Treatment, The American Journal of Surgery, The Journal of Immunology, Annals of Surgical Oncology and Annals of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.